We suppose that local injection of AAV-FST, AAV-PRDM16, or AAV-FoxP4 vectors do not efficiently target subcutaneous and visceral fat depots to alleviate obesity in mice for long periods of time. The gene discussed is FST; the disease is obesity due to melanocortin 4 receptor deficiency.